← Open Payments lookup

JOCELYN URBANO: Open Payments

NPI 1770037467 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,569 in 13 payments from 11 companies in 2025. Trend: 2023 $1,751 · 2024 $2,195 · 2025 $1,569

Food & beverage: $1,569
CompanyPaymentsAmount
Novo Nordisk Inc3$348
Dexcom, Inc.1$150
Janssen Pharmaceuticals, Inc1$146
Corcept Therapeutics1$127
Otsuka Pharmaceutical Development & Commercialization, Inc.1$125
Axsome Therapeutics, Inc.1$125
Supernus Pharmaceuticals, Inc.1$122
Takeda Pharmaceuticals U.S.A., Inc.1$121
KYOWA KIRIN, INC.1$110
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$107

Products named: DEXCOM G7 GSS (161), INVEGA SUSTENNA, Korlym, REXULTI, Auvelity, Qelbree, GATTEX, CAPLYTA.

Industry payments across TX — which companies pay providers there.